Search Results

Test Catalog

LDAI - Overview: Progentec aiSLE DX Lupus Disease Activity Index, Plasma

Aiding in the assessment of current systemic lupus erythematosus disease activity when used in conjunction with standard clinical assessment

PIK3T - Overview: PIK3CA Mutation Analysis, Tumor

Identification of hormone receptor positive and human epidermal growth factor receptor 2 negative (HR+/HER2-) advanced breast cancer tumors that may be eligible for treatment with targeted kinase inhibitor therapy (eg, alpelisib).

PC2TC - Overview: Purkinje Cell Cytoplasmic Antibody Type 2 (PCA-2) Titer, Spinal Fluid

Evaluating patients who present with a subacute neurological disorder of undetermined etiology and have risk factors for lung cancer Reporting an end titer result from spinal fluid specimens

PC1TC - Overview: Purkinje Cell Cytoplasmic Antibody Type 1 (PCA-1) Titer, Spinal Fluid

Identifying female patients whose subacute cerebellar degeneration or peripheral neuropathy is due to a remote (autoimmune) effect of gynecologic or breast carcinoma Reporting an end titer result from spinal fluid specimens

PGSN - Overview: Progesterone, Serum

Ascertaining whether ovulation occurred in a menstrual cycle Assessment of infertility Evaluation of abnormal uterine bleeding Evaluation of placental health in high-risk pregnancy Determining the effectiveness of progesterone...

PRSSZ - Overview: PRSS1 Gene, Full Gene Analysis, Varies

Confirmation of suspected clinical diagnosis of hereditary pancreatitis (HP) in patients with chronic pancreatitis Identification of familial PRSSI mutation to allow for predictive and diagnostic testing in family members

PRCAL - Overview: Procalcitonin, Serum

Monitoring antibiotic therapy and all-cause mortality for patients diagnosed with severe sepsis or septic shock in the Intensive Care Unit (ICU) or when obtained in the emergency department or other medical wards prior to ICU admission

TOXB - Overview: Toxoplasma gondii, Molecular Detection, PCR, Blood

Supporting the diagnosis of active toxoplasmosis, particularly in immunocompromised individuals

AN3TS - Overview: Antineuronal Nuclear Antibody Type 3 (ANNA-3) Titer, Serum

Evaluating patients who present with a subacute neurological disorder of undetermined etiology and have risk factors for primary lung carcinoma Reporting an end titer result from serum specimens

Site Search

Week in Review: January 20 - Insights

Topic highlights include: Phoenix Children’s opens specialty clinic at Avondale campus, Moderna says RSV vaccine is effective in older adults, WHO questions severity of XBB.1.5 COVID subvariant as U.S. cases rise

Week in Review: May 20 - Insights

Today's highlights include: US at risk of COVID-19 drug shortages this summer, Rochester startup Vyriad developing cancer-fighting viruses, and CDC expresses concern about possibility of undetected monkeypox spread in U.K.

Testing Archives - Page 20 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Research Roundup Archives - Page 20 of 29 - Insights

Skip to Content MayoACCESS MayoLINK...

What's New in Health Care Reform: Feb. 20 - Insights

Top highlights include: Flu shot kept about 50% from going to doctor, racial disparities in cancer incidence and survival rates are narrowing, having anesthesia once as a baby does not cause learning disabilities, personalized diet predicts...